b-Aryl- and b-Amino-Substituted Aliphatic Esters
FULL PAPER
(75.0 mg, 0.5 mmol) and sodium tetrakis(4-methoxyphenyl)borate (2g)
(462 mg, 1.0 mmol). Purification by flash column chromatography (SiO2,
ethyl acetate/hexane 1:10) yielded 3m as a colorless liquid (56 mg, 50%).
1H NMR (400 MHz, CDCl3): d=7.10 (m, J=8.61 Hz, 2H) 6.83 (m, J=
8.61 Hz, 2H) 4.03 (q, J=7.04 Hz, 2H) 3.78 (s, 3H) 3.06 (t, J=6.65 Hz,
1H) 2.48–2.63 (m, 2H) 1.50–1.65 (m, 2H) 1.11–1.25 (m, 5H) 0.82–
0.91 ppm (m, 3H); 13C NMR (101 MHz, CDCl3): d=172.5, 157.9, 136.1,
128.3, 113.6, 60.1, 55.1, 42.0, 41.1, 38.5, 20.4, 14.1, 13.9 ppm; MS (Ion
trap, EI): m/z (%): 250 [M+] (26), 207 (43), 165 (85), 134 (19), 121 (100),
91 (16), 77 (9); IR (NaCl): n˜ =2956 (s), 1734 (s), 1513 (s), 1248 cmÀ1 (s).
(70), 184 (80), 156 (26), 126 (100), 110 (10), 96 (16), 42 (12); HRMS (EI):
m/z: calcd for C12H23NO2: 213.1729; found: 213.1742; IR (NaCl): n˜ =
2931 (vs), 1735 (vs), 1158 cmÀ1 (s).
Ethyl 3-(4-methylpiperidin-1-yl)pentanoate (5e): Compound 5e was syn-
thesized by following the general procedure from ethyl 4-pentenoate (1c)
(131 mg, 1.0 mmol) and 4-methylpiperidine (4e) (1012 mg, 1205 mL,
10.0 mmol). Purification by flash column chromatography (SiO2, diethyl
ether/hexane 1:1) yielded 5e as
a colorless liquid (162 mg, 71%).
1H NMR (400 MHz, CDCl3): d=4.10 (q, J=7.0 Hz, 2H) 2.88 (quin, J=
6.9 Hz, 1H) 2.68 (t, J=10.8 Hz, 2H) 2.47 (dd, J=14.1, 6.7 Hz, 1H) 2.08–
2.29 (m, 3H) 1.45–1.66 (m, 3H) 1.21–1.35 (m, 5H) 1.04–1.18 (m, 2H)
0.84–0.96 ppm (m, 6H); 13C NMR (101 MHz, CDCl3): d=173.4, 63.3,
60.1, 49.5, 47.9, 35.3, 34.9, 34.9, 31.3, 23.8, 22.0, 14.2, 11.4 ppm; MS (Ion
trap, EI): m/z (%): 228 [M+] (94), 198 (85), 170 (14), 140 (100), 110 (26),
42 (14); HRMS (EI): m/z: calcd for C13H26NO2: 227.1885; found:
227.1873; IR (NaCl): n˜ =2921 (vs), 1735 (vs), 1166 cmÀ1 (m).
General procedure for the isomerization–conjugate addition reaction of
amines (Table 6): An oven-dried 20 mL crimp top vial was charged with
(acetylacetonato)dicarbonylrhodium(I) (1.5 mol%), biphephos (1.5
mol%), and a stir bar, sealed with a Teflon septum and evacuated-
purged with argon three times. Subsequently, toluene (2 mLmmolÀ1
ester), olefinic ester 1 (0.5–1.0 mmol), and the amine (4) (10.0 equiv)
were added by hypodermic syringe, and the reaction mixture was stirred
for 20 h at 1008C. After cooling to RT, the solvent was removed in vacuo
and b-amino ester 5 was obtained after flash column chromatography
(SiO2, ethyl acetate/hexane or diethyl ether/hexane).
Ethyl 3-(4-carboxyethylpiperidin-1-yl)pentanoate (5 f): Compound 5 f
was synthesized by following the general procedure from ethyl 4-pente-
noate (1c) (131 mg, 1.0 mmol) and ethyl isonipecotate (4 f) (1604 mg,
1573 mL, 10.0 mmol). Purification by flash column chromatography (SiO2,
diethyl ether/hexane 1:1) yielded 5 f as a colorless liquid (135 mg, 47%).
1H NMR (400 MHz, CDCl3): d=4.04–4.14 (m, 4H) 2.88 (quin, J=
7.0 Hz, 1H) 2.68–2.78 (m, 2H) 2.42 (dd, J=14.1, 7.0 Hz, 1H) 2.14–2.29
(m, 4H) 1.76–1.87 (m, 2H) 1.46–1.68 (m, 3H) 1.17–1.34 (m, 7H)
0.86 ppm (t, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3): d=175.2,
173.1, 63.3, 60.1, 48.3, 47.3, 41.6, 35.5, 28.8, 23.5, 14.2, 14.1, 11.4 ppm; MS
(Ion trap, EI): m/z (%): 286 [M+] (22), 257 (15), 256 (100), 210 (57), 199
(22), 170 (31), 55 (20); HRMS (EI): m/z: calcd for C15H27NO4: 285.1940;
found: 285.1952; IR (NaCl): n˜ =2935 (vs), 1733 (s), 1375 cmÀ1 (m).
Ethyl 3-(cyclohexylamino)pentanoate (5a): Compound 5a was synthe-
sized by following the general procedure from ethyl 4-pentenoate (1c)
(131 mg, 1.0 mmol) and cyclohexylamine (4a) (992 mg, 1145 mL,
10.0 mmol). Purification by flash column chromatography (SiO2, diethyl
ether/hexane 1:1) yielded 5a as
a colorless liquid (100 mg, 44%).
1H NMR (400 MHz, CDCl3): d=4.12 (q, J=7.0 Hz, 2H) 3.00 (quin, J=
6.1 Hz, 1H) 2.28–2.51 (m, 3H) 1.83 (d, J=11.0 Hz, 2H) 1.70 (d, J=
12.9 Hz, 2H) 1.58 (d, J=11.7 Hz, 1H) 1.44 (tq, J=14.2, 6.9 Hz, 2H)
1.14–1.30 (m, 6H) 0.97–1.09 (m, 2H) 0.89 ppm (t, J=7.4 Hz, 3H);
13C NMR (101 MHz, CDCl3): d=172.7, 60.2, 53.6, 52.8, 39.7, 34.1, 34.0,
27.7, 26.1, 25.1, 14.2, 10.0 ppm; MS (Ion trap, EI): m/z (%): 228 [M+]
(100), 198 (37), 184 (16), 140 (38), 110 (21), 96 (20), 55 (20); HRMS (EI):
m/z: C13H25NO2 requires 227.1885; found: 227.1869; IR (NaCl): n˜ =2927
(vs), 1731 (s), 1178 cmÀ1 (m).
Ethyl 3-(pyrrolidin-1-yl)undecanoate (5g): Compound 5g was synthe-
sized by following the general procedure from ethyl 10-undecenoate (1d)
(224 mg, 255 mL, 1.0 mmol) and pyrrolidine (4c) (718 mg, 830 mL,
10.0 mmol). Purification by flash column chromatography (SiO2, diethyl
ether/hexane 1:1) yielded 5g as a colorless, viscous liquid (72 mg, 25%).
1H NMR (600 MHz, CDCl3): d=4.12 (qd, J=7.1, 1.2 Hz, 2H) 2.90 (t, J=
5.6 Hz, 1H) 2.50–2.57 (m, 5H) 2.33 (dd, J=14.8, 7.1 Hz, 1H) 1.72 (dt,
J=6.4, 3.3 Hz, 4H) 1.49–1.55 (m, 1H) 1.40–1.46 (m, 1H) 1.30–1.33 (m,
2H) 1.22–1.29 (m, 13H) 0.86 ppm (t, J=7.0 Hz, 3H); 13C NMR
(151 MHz, CDCl3): d=173.1, 60.2, 59.1, 49.7, 36.9, 32.9, 31.9, 29.9, 29.5,
29.3, 25.6, 23.5, 22.7, 14.2, 14.1 ppm; MS (Ion trap, EI): m/z (%): 285
[M+] (100), 196 (73), 170 (100), 142 (31), 110 (46), 84 (16), 42 (32);
HRMS (EI): m/z: calcd for C17H33NO2: 283.2511; found: 283.2507; IR
(NaCl): n˜ =2955 (vs), 2853 (s), 1733 (s), 1162 cmÀ1 (m).
Ethyl 3-butylaminopentanoate (5b): Compound 5b was synthesized by
following the general procedure from ethyl 4-pentenoate (1c) (131 mg,
1.0 mmol) and n-butylamine (4b) (731 mg, 988 mL, 10.0 mmol). Purifica-
tion by flash column chromatography (SiO2, diethyl ether/hexane 1:1)
yielded 5b as a light-yellow liquid (122 mg, 62%). 1H NMR (400 MHz,
CDCl3): d=4.11 (qd, J=7.1, 1.8 Hz, 2H) 2.82–2.93 (m, 1H) 2.49–2.64 (m,
2H) 2.32–2.43 (m, 2H) 1.29–1.48 (m, 6H) 1.23 (td, J=7.2, 2.0 Hz, 3H)
0.83–0.98 ppm (m, 6H); 13C NMR (101 MHz, CDCl3): d=172.7, 60.2,
56.1, 46.5, 38.8, 32.4, 26.9, 20.4, 14.1, 13.9, 9.9 ppm; MS (Ion trap, EI):
m/z (%): 202 [M+] (100), 172 (29), 126 (13), 114 (39), 70 (20), 57 (22);
HRMS (EI): m/z: calcd for C11H23NO2: 201.1729; found: 201.1730; IR
(NaCl): n˜ =2929 (vs), 1735 (s), 1184 cmÀ1 (m).
Ethyl 3-(pyrrolidin-1-yl)octadecanoate (5h): Compound 5h was synthe-
sized by following the general procedure from ethyl oleate (1 f) (98%
purity, 317 mg, 368 mL, 1.0 mmol) and pyrrolidine (4c) (718 mg, 830 mL,
10.0 mmol). Purification by flash column chromatography (SiO2, diethyl
ether/hexane 1:1) yielded 5h as a colorless, viscous liquid (65 mg, 17%).
1H NMR (600 MHz, CDCl3): d=4.12 (qd, J=7.2, 1.1 Hz, 2H) 2.88–2.93
(m, 1H) 2.55 (s, 4H) 2.52 (d, J=5.7 Hz, 1H) 2.33 (dd, J=14.7, 7.0 Hz,
1H) 1.73 (s, 4H) 1.49–1.56 (m, 1H) 1.40–1.47 (m, 1H) 1.31–1.33 (m, 1H)
1.23–1.30 (m, 28H) 0.87 ppm (t, J=7.0 Hz, 3H); 13C NMR (151 MHz,
CDCl3): d=173.1, 60.2, 59.1, 49.8, 36.9, 32.9, 31.9, 29.9, 29.7, 29.7, 29.6,
29.4, 25.6, 23.5, 22.7, 14.2, 14.1 ppm; MS (Ion trap, EI): m/z (%): 381
[M+] (1), 295 (59), 171 (100), 142 (11), 70 (6), 41 (7); HRMS (EI): m/z:
calcd for C24H47NO2: 381.3607; found: 381.3602; IR (NaCl): n˜ =2923 (vs),
2851 (s), 1737 (m), 1238 (w), 1178 cmÀ1 (w).
Ethyl 3-(pyrrolidin-1-yl)pentanoate (5c): Compound 5c was synthesized
by following the general procedure from ethyl 4-pentenoate (1c)
(131 mg, 1.0 mmol) and pyrrolidine (4c) (718 mg, 830 mL, 10.0 mmol).
Purification by flash column chromatography (SiO2, diethyl ether/hexane
1:1) yielded 5c as a colorless liquid (178 mg, 89%). 1H NMR (600 MHz,
CDCl3): d=4.11 (q, J=7.2 Hz, 2H) 2.82 (ddd, J=12.2, 6.8, 5.4 Hz, 1H)
2.50–2.56 (m, 5H) 2.34 (dd, J=14.7, 7.2 Hz, 1H) 1.70–1.75 (m, 4H) 1.53–
1.59 (m, 1H) 1.50 (dt, J=14.3, 7.1 Hz, 1H) 1.24 (t, J=7.1 Hz, 3H)
0.91 ppm (t, J=7.5 Hz, 3H); 13C NMR (151 MHz, CDCl3): d=173.1,
60.5, 60.2, 50.0, 36.6, 25.5, 23.5, 14.2, 9.9 ppm; MS (Ion trap, EI): m/z
(%): 200 [M+] (33), 170 (59), 142 (39), 112 (100), 96 (14), 70 (14); ele-
mental analysis calcd C 66.2, N 7.03, H 10.62; found: C 66.12, N 6.99, H
10.50; IR (NaCl): n˜ =2965 (vs), 1735 (s), 1154 cmÀ1 (m).
Ethyl 3-(2-oxopiperidin-1-yl)pentanoate (5i): Compound 5i was synthe-
sized by following the general procedure from ethyl 4-pentenoate (1c)
(131 mg, 1.0 mmol) and 2-piperidinone (4g) (506 mg, 5.0 mmol). Purifica-
tion by flash column chromatography (SiO2, ethyl acetate/hexane 1:1)
Ethyl 3-(piperidin-1-yl)pentanoate (5d): Compound 5d was synthesized
by following the general procedure from ethyl 4-pentenoate (1c)
(131 mg, 1.0 mmol) and piperidine (4d) (851 mg, 988 mL, 10.0 mmol). Pu-
rification by flash column chromatography (SiO2, diethyl ether/hexane
1:1) yielded 5d as a colorless liquid (158 mg, 74%). 1H NMR (400 MHz,
CDCl3): d=4.05–4.16 (m, 2H) 2.79–2.89 (m, 1H) 2.34–2.55 (m, 5H)
2.13–2.23 (m, 1H) 1.44–1.57 (m, 5H) 1.19–1.40 (m, 6H) 0.82–0.95 ppm
(m, 3H); 13C NMR (101 MHz, CDCl3): d=173.4, 63.7, 60.0, 49.4, 35.3,
26.5, 24.9, 23.7, 14.2, 11.4 ppm; MS (Ion trap, EI): m/z (%): 214 [M+]
yielded 5i as
a
colorless liquid (82 mg, 36%). 1H NMR (400 MHz,
CDCl3): d=4.64–4.74 (m, 1H) 4.03 (qd, J=7.2, 2.3 Hz, 2H) 3.05–3.17 (m,
2H) 2.46–2.57 (m, 1H) 2.25–2.44 (m, 3H) 1.64–1.76 (m, 4H) 1.44–1.63
(m, 2H) 1.17 (td, J=7.1, 2.5 Hz, 3H) 0.80 ppm (td, J=7.3, 2.2 Hz, 3H);
13C NMR (101 MHz, CDCl3): d=171.2, 169.9, 60.3, 52.4, 42.6, 37.1, 32.4,
24.5, 23.0, 20.7, 14.0, 10.5 ppm; MS (Ion trap, EI): m/z (%): 228 [M+]
(52), 182 (41), 170 (55), 152 (100), 140 (79), 100 (74), 55 (53); HRMS
Chem. Eur. J. 2011, 17, 9508 – 9519
ꢄ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
9517